These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 17349925

  • 1. Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and -independent pathways.
    Wang X, Cederbaum AI.
    Free Radic Biol Med; 2007 Apr 01; 42(7):971-84. PubMed ID: 17349925
    [Abstract] [Full Text] [Related]

  • 2. S-adenosyl-L-methionine decreases the elevated hepatotoxicity induced by Fas agonistic antibody plus acute ethanol pretreatment in mice.
    Wang X, Cederbaum AI.
    Arch Biochem Biophys; 2008 Sep 01; 477(1):1-11. PubMed ID: 18482574
    [Abstract] [Full Text] [Related]

  • 3. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice.
    Wang X, Lu Y, Cederbaum AI.
    Hepatology; 2005 Aug 01; 42(2):400-10. PubMed ID: 16025513
    [Abstract] [Full Text] [Related]

  • 4. S-adenosyl-L-methionine attenuates hepatotoxicity induced by agonistic Jo2 Fas antibody following CYP2E1 induction in mice.
    Wang X, Cederbaum AI.
    J Pharmacol Exp Ther; 2006 Apr 01; 317(1):44-52. PubMed ID: 16373529
    [Abstract] [Full Text] [Related]

  • 5. Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase.
    Wang X, Lu Y, Xie B, Cederbaum AI.
    Free Radic Biol Med; 2009 Sep 01; 47(5):518-28. PubMed ID: 19477265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.
    Gastroenterology; 2001 Apr 01; 120(5):1251-62. PubMed ID: 11266388
    [Abstract] [Full Text] [Related]

  • 9. Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivo.
    Wang X, Wu D, Yang L, Gan L, Cederbaum AI.
    Free Radic Biol Med; 2013 Oct 01; 63():175-86. PubMed ID: 23669278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole.
    Lu Y, Wang X, Cederbaum AI.
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug 01; 289(2):G308-19. PubMed ID: 15845871
    [Abstract] [Full Text] [Related]

  • 12. S-adenosyl methionine protects ob/ob mice from CYP2E1-mediated liver injury.
    Dey A, Caro AA, Cederbaum AI.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul 01; 293(1):G91-103. PubMed ID: 17446309
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment.
    Cederbaum AI.
    Drug Metabol Drug Interact; 2012 Jul 01; 27(3):125-44. PubMed ID: 23104821
    [Abstract] [Full Text] [Related]

  • 15. Autophagy Protects against CYP2E1/Chronic Ethanol-Induced Hepatotoxicity.
    Lu Y, Cederbaum AI.
    Biomolecules; 2015 Oct 16; 5(4):2659-74. PubMed ID: 26501338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice.
    Sinclair JF, Szakacs JG, Wood SG, Walton HS, Bement JL, Gonzalez FJ, Jeffery EH, Wrighton SA, Bement WJ, Sinclair PR.
    Toxicol Appl Pharmacol; 2000 Oct 15; 168(2):114-22. PubMed ID: 11032766
    [Abstract] [Full Text] [Related]

  • 20. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
    Wang X, Wu D, Yang L, Cederbaum AI.
    Hepatology; 2011 Nov 15; 54(5):1753-66. PubMed ID: 21748763
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.